11 resultados para Boyer, E.
em Université de Lausanne, Switzerland
Resumo:
(Résumé de l'ouvrage) Cette nouvelle traduction de la Bible est la première traduction française de la Bible réalisée en commun par des spécialistes des langues et des textes bibliques et des écrivains. Entièrement originale, elle a été élaborée d'après les langues sources de la Bible (Hébreu, Araméen, Grec), et selon les dernières éditions critiques. Chaque livre biblique a été confié à un tandem composé d'un bibliste et d'un écrivain, qui ont travaillé au coude à coude pendant 6 ans. Une idée forte a prévalu : jouer sur la pluralité des genres, des écritures, des interprétations, aboutissant à une Bible à plusieurs voix, qui transmet dans la langue et les littératures françaises contemporaines la diversité des genres littéraires, des styles, des formes, des auteurs, des inspirations, des traditions... Cette nouvelle traduction est le fruit d'une collaboration internationale exceptionnelle entre 20 écrivains et poètes contemporains francophones (parmi lesquels François Bon, Emmanuel Carrère, Florence Delay, Jean Echenoz, Jacques Roubaud...) et 27 spécialistes de la Bible et des langues anciennes. « Bible d'une nouvelle génération », cette Bible renoue avec l'histoire de notre culture. Elle affirme que cette histoire n'est pas close, que la Bible garde l'étonnante capacité de solliciter et de provoquer.
Resumo:
(Résumé de l'ouvrage) Cette nouvelle traduction de la Bible est la première traduction française de la Bible réalisée en commun par des spécialistes des langues et des textes bibliques et des écrivains. Entièrement originale, elle a été élaborée d'après les langues sources de la Bible (Hébreu, Araméen, Grec), et selon les dernières éditions critiques. Chaque livre biblique a été confié à un tandem composé d'un bibliste et d'un écrivain, qui ont travaillé au coude à coude pendant 6 ans. Une idée forte a prévalu : jouer sur la pluralité des genres, des écritures, des interprétations, aboutissant à une Bible à plusieurs voix, qui transmet dans la langue et les littératures françaises contemporaines la diversité des genres littéraires, des styles, des formes, des auteurs, des inspirations, des traditions... Cette nouvelle traduction est le fruit d'une collaboration internationale exceptionnelle entre 20 écrivains et poètes contemporains francophones (parmi lesquels François Bon, Emmanuel Carrère, Florence Delay, Jean Echenoz, Jacques Roubaud...) et 27 spécialistes de la Bible et des langues anciennes. « Bible d'une nouvelle génération », cette Bible renoue avec l'histoire de notre culture. Elle affirme que cette histoire n'est pas close, que la Bible garde l'étonnante capacité de solliciter et de provoquer.
Resumo:
Percutaneous transluminal renal angioplasty (PTRA) is an invasive technique that is costly and involves the risk of complications and renal failure. The ability of PTRA to reduce the administration of antihypertensive drugs has been demonstrated. A potentially greater benefit, which nevertheless remains to be proven, is the deferral of the need for chronic dialysis. The aim of the study (ANPARIA) was to assess the appropriateness of PTRA to impact on the evolution of renal function. A standardized expert panel method was used to assess the appropriateness of medical treatment alone or medical treatment with revascularization in various clinical situations. The choice of revascularization by either PTRA or surgery was examined for each clinical situation. Analysis was based on a detailed literature review and on systematically elicited expert opinion, which were obtained during a two-round modified Delphi process. The study provides detailed responses on the appropriateness of PTRA for 1848 distinct clinical scenarios. Depending on the major clinical presentation, appropriateness of revascularization varied from 32% to 75% for individual scenarios (overal 48%). Uncertainty as to revascularization was 41% overall. When revascularization was appropriate, PTRA was favored over surgery in 94% of the scenarios, except in certain cases of aortic atheroma where sugery was the preferred choice. Kidney size [7 cm, absence of coexisting disease, acute renal failure, a high degree of stenosis (C70%), and absence of multiple arteries were identified as predictive variables of favorable appropriateness ratings. Situations such as cardiac failure with pulmonary edema or acute thrombosis of the renal artery were defined as indications for PTRA. This study identified clinical situations in which PTRA or surgery are appropriate for renal artery disease. We built a decision tree which can be used via Internet: the ANPARIA software (http://www.chu-clermontferrand.fr/anparia/). In numerous clinical situations uncertainty remains as to whether PTRA prevents deterioration of renal function.
Resumo:
In 2008 we published the first set of guidelines for standardizing research in autophagy. Since then, research on this topic has continued to accelerate, and many new scientists have entered the field. Our knowledge base and relevant new technologies have also been expanding. Accordingly, it is important to update these guidelines for monitoring autophagy in different organisms. Various reviews have described the range of assays that have been used for this purpose. Nevertheless, there continues to be confusion regarding acceptable methods to measure autophagy, especially in multicellular eukaryotes. A key point that needs to be emphasized is that there is a difference between measurements that monitor the numbers or volume of autophagic elements (e.g., autophagosomes or autolysosomes) at any stage of the autophagic process vs. those that measure flux through the autophagy pathway (i.e., the complete process); thus, a block in macroautophagy that results in autophagosome accumulation needs to be differentiated from stimuli that result in increased autophagic activity, defined as increased autophagy induction coupled with increased delivery to, and degradation within, lysosomes (in most higher eukaryotes and some protists such as Dictyostelium) or the vacuole (in plants and fungi). In other words, it is especially important that investigators new to the field understand that the appearance of more autophagosomes does not necessarily equate with more autophagy. In fact, in many cases, autophagosomes accumulate because of a block in trafficking to lysosomes without a concomitant change in autophagosome biogenesis, whereas an increase in autolysosomes may reflect a reduction in degradative activity. Here, we present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes. These guidelines are not meant to be a formulaic set of rules, because the appropriate assays depend in part on the question being asked and the system being used. In addition, we emphasize that no individual assay is guaranteed to be the most appropriate one in every situation, and we strongly recommend the use of multiple assays to monitor autophagy. In these guidelines, we consider these various methods of assessing autophagy and what information can, or cannot, be obtained from them. Finally, by discussing the merits and limits of particular autophagy assays, we hope to encourage technical innovation in the field.
Resumo:
Cet article postule que la combinaison d'une approche en termes de science politique (analyse des politiques publiques) et d'économie institutionnelle des ressources (théorie des droits de propriété) permet l'identification des dimensions régulatrices les plus importantes permettant d'expliquer l'usage (non) durable des ressources naturelles et culturelles. Sur cette base, il développe un cadre d'analyse novateur, celui des régimes institutionnels de ressources (RIR), qui est ensuite confronté au corpus de la théorie française de la régulation (TR, telle que formalisée notamment par M. Aglietta, R. Boyer et A. Lipietz) de manière à identifier, aussi bien les convergences, que les complémentarités entre les RIR et la TR. Nous développons ainsi l'idée que l'une des contributions majeures des RIR à la TR sous l'angle de la durabilité consiste dans sa capacité à décrire les différentes configurations de régimes de ressource et à expliquer, voire prévoir, leurs effets sur la durabilité de la ressource.
Resumo:
Surface characteristics (area, chemical reactivity) play an important role in cell response to nanomaterials. The aim of this study was to evaluate the oxidative and inflammatory effects of multi−wall carbon nanotubes (MWCNT) uncoated (P0) or coated with carboxylic polyacid or polystyrene polybutadiene polymetacrylate of methyl polymers (P1 and P2 respectively) on murine macrophages (RAW 264.7 cell line). Carbon black nanoparticles (CB, diameter 95 nm) and crocidolite fibers (diameter: 80 nm, length: < 10 μm) were used as controls. Surface functional groups present on MWCNTs were analyzed by Knudsen flow reactor. The amount of acidic sites was P1> P0> P2, for basic sites was P0> P1>> P2 and for oxidizable sites was P0> P2> P1. In contact with cells, P2 formed smaller aggregates than P0 and P1, which were of similar size. Optical microscopy showed the formation of vacuoles after exposure only to P0, P1 and crocidolite. Incubation of cells with P0, P1 and crocidolite fibers induced a significant and similar decrease in metabolic activity, whereas P2 and CB had no effect. Cell number and membrane permeability were unmodified by incubation with the different particles. Incubation of macrophages with P0, P1 and crocidolite induced a dose− and time−dependent increase in mRNA expression of oxidative stress marker (HO−1, GPX1) and inflammatory mediators (TNF−a, MIP−2). No such responses were observed with P2 and CB. In conclusion, MWCNT coated with a carboxylic polyacid polymer exerted similar oxidative and inflammatory effects to uncoated MWCNT. By contrast, no such effects were observed with MWCNT coated with a polystyrene−based polymer. This kind of coating could be useful to decrease MWCNT toxicity.
Resumo:
The Cancer Vaccine Consortium of the Sabin Vaccine Institute (CVC/SVI) is conducting an ongoing large-scale immune monitoring harmonization program through its members and affiliated associations. This effort was brought to life as an external validation program by conducting an international Elispot proficiency panel with 36 laboratories in 2005, and was followed by a second panel with 29 participating laboratories in 2006 allowing for application of learnings from the first panel. Critical protocol choices, as well as standardization and validation practices among laboratories were assessed through detailed surveys. Although panel participants had to follow general guidelines in order to allow comparison of results, each laboratory was able to use its own protocols, materials and reagents. The second panel recorded an overall significantly improved performance, as measured by the ability to detect all predefined responses correctly. Protocol choices and laboratory practices, which can have a dramatic effect on the overall assay outcome, were identified and lead to the following recommendations: (A) Establish a laboratory SOP for Elispot testing procedures including (A1) a counting method for apoptotic cells for determining adequate cell dilution for plating, and (A2) overnight rest of cells prior to plating and incubation, (B) Use only pre-tested serum optimized for low background: high signal ratio, (C) Establish a laboratory SOP for plate reading including (C1) human auditing during the reading process and (C2) adequate adjustments for technical artifacts, and (D) Only allow trained personnel, which is certified per laboratory SOPs to conduct assays. Recommendations described under (A) were found to make a statistically significant difference in assay performance, while the remaining recommendations are based on practical experiences confirmed by the panel results, which could not be statistically tested. These results provide initial harmonization guidelines to optimize Elispot assay performance to the immunotherapy community. Further optimization is in process with ongoing panels.